606 related articles for article (PubMed ID: 26175217)
21. Protection against RAGE-mediated neuronal cell death by sRAGE-secreting human mesenchymal stem cells in 5xFAD transgenic mouse model.
Son M; Oh S; Park H; Ahn H; Choi J; Kim H; Lee HS; Lee S; Park HJ; Kim SU; Lee B; Byun K
Brain Behav Immun; 2017 Nov; 66():347-358. PubMed ID: 28760504
[TBL] [Abstract][Full Text] [Related]
22. A Novel, Multi-Target Natural Drug Candidate, Matrine, Improves Cognitive Deficits in Alzheimer's Disease Transgenic Mice by Inhibiting Aβ Aggregation and Blocking the RAGE/Aβ Axis.
Cui L; Cai Y; Cheng W; Liu G; Zhao J; Cao H; Tao H; Wang Y; Yin M; Liu T; Liu Y; Huang P; Liu Z; Li K; Zhao B
Mol Neurobiol; 2017 Apr; 54(3):1939-1952. PubMed ID: 26899576
[TBL] [Abstract][Full Text] [Related]
23. RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling.
Chaney MO; Stine WB; Kokjohn TA; Kuo YM; Esh C; Rahman A; Luehrs DC; Schmidt AM; Stern D; Yan SD; Roher AE
Biochim Biophys Acta; 2005 Jun; 1741(1-2):199-205. PubMed ID: 15882940
[TBL] [Abstract][Full Text] [Related]
24. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
Gasparotto J; Girardi CS; Somensi N; Ribeiro CT; Moreira JCF; Michels M; Sonai B; Rocha M; Steckert AV; Barichello T; Quevedo J; Dal-Pizzol F; Gelain DP
J Biol Chem; 2018 Jan; 293(1):226-244. PubMed ID: 29127203
[TBL] [Abstract][Full Text] [Related]
25. Aβ-AGE aggravates cognitive deficit in rats via RAGE pathway.
Chen C; Li XH; Tu Y; Sun HT; Liang HQ; Cheng SX; Zhang S
Neuroscience; 2014 Jan; 257():1-10. PubMed ID: 24188791
[TBL] [Abstract][Full Text] [Related]
26. Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease.
Walker D; Lue LF; Paul G; Patel A; Sabbagh MN
Expert Opin Investig Drugs; 2015 Mar; 24(3):393-9. PubMed ID: 25586103
[TBL] [Abstract][Full Text] [Related]
27. The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease.
Wan W; Chen H; Li Y
Int J Neurosci; 2014 Feb; 124(2):75-81. PubMed ID: 23855502
[TBL] [Abstract][Full Text] [Related]
28. Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease.
Leclerc E; Sturchler E; Vetter SW; Heizmann CW
Rev Neurosci; 2009; 20(2):95-110. PubMed ID: 19774788
[TBL] [Abstract][Full Text] [Related]
29. RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.
Yan SS; Chen D; Yan S; Guo L; Du H; Chen JX
Front Biosci (Schol Ed); 2012 Jan; 4(1):240-50. PubMed ID: 22202057
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.
Sasaki N; Toki S; Chowei H; Saito T; Nakano N; Hayashi Y; Takeuchi M; Makita Z
Brain Res; 2001 Jan; 888(2):256-262. PubMed ID: 11150482
[TBL] [Abstract][Full Text] [Related]
31. CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice.
Bhargavan B; Woollard SM; McMillan JE; Kanmogne GD
Mol Neurodegener; 2021 Nov; 16(1):78. PubMed ID: 34809709
[TBL] [Abstract][Full Text] [Related]
32. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
[TBL] [Abstract][Full Text] [Related]
33. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
[TBL] [Abstract][Full Text] [Related]
34. Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9.
Ashok A; Rai NK; Raza W; Pandey R; Bandyopadhyay S
Neurobiol Dis; 2016 Nov; 95():179-93. PubMed ID: 27431094
[TBL] [Abstract][Full Text] [Related]
35. Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE).
Onyango IG; Tuttle JB; Bennett JP
Mol Cell Neurosci; 2005 Jun; 29(2):333-43. PubMed ID: 15911356
[TBL] [Abstract][Full Text] [Related]
36. Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer's disease.
Kojro E; Postina R
J Alzheimers Dis; 2009; 16(4):865-78. PubMed ID: 19387119
[TBL] [Abstract][Full Text] [Related]
37. Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis.
Zhu D; Su Y; Fu B; Xu H
Mol Neurobiol; 2018 Sep; 55(9):7118-7131. PubMed ID: 29383689
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiological Links Among Hypertension and Alzheimer's Disease.
Carnevale D; Perrotta M; Lembo G; Trimarco B
High Blood Press Cardiovasc Prev; 2016 Mar; 23(1):3-7. PubMed ID: 26054481
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
[TBL] [Abstract][Full Text] [Related]
40. Antidiabetic drugs restore abnormal transport of amyloid-β across the blood-brain barrier and memory impairment in db/db mice.
Chen F; Dong RR; Zhong KL; Ghosh A; Tang SS; Long Y; Hu M; Miao MX; Liao JM; Sun HB; Kong LY; Hong H
Neuropharmacology; 2016 Feb; 101():123-36. PubMed ID: 26211973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
